Hybrid immunity elicits potent cross-variant ADCC against SARS-CoV-2 through a combination of anti-S1 and S2 antibodies https://www.biorxiv.org/content/10.1101/2023.03.09.531709v1?med=mas
Hybrid immunity elicits potent cross-variant ADCC against SARS-CoV-2 through a combination of anti-S1 and S2 antibodies https://www.biorxiv.org/content/10.1101/2023.03.09.531709v1?med=mas